Skip to content
★ Sign in to follow
WL

Wouter Latour

Board Director
Director
Vaxart, Inc.
Total declarations
9
Company
1
▲ Purchases (1 ops.)
€46k
▼ Sales (4 ops.)
€3.7M

Latest filing published 10 May 2021 for Vaxart, Inc., €542k.

Filing timeline

BuySale
Wouter Latour

Insider track record

Disclosed buys
1
Disclosed sells
4
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 30 Sept 2019 · 2597 days ago · €46k
    +1800.0%
    Entry US$0.35 · Close at T+365 US$6.65

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Wouter Latour: trading record in brief

Wouter Latour (board member) discloses dealings in Vaxart, Inc. to SEC (Form 4). In total, 9 filings cover trades dated from 30 September 2019 to 7 May 2021.

Market trades split into 1 purchase (€46k) and 4 sales (€3.7M). The net balance comes to €3.6M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 3 option exercises. Since January 2021: no purchases and 3 sales on the market.

On 10 May 2021 came the latest disclosure, an open-market sale for €542k in Vaxart, Inc. The last insider purchase was made public on 30 September 2019, 2,597 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Wouter Latour

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▼
    DirectorExecutivesVaxart, Inc.
    654,000 USD12SEC
    100,000 shares@ US$6.5413.1% of flowCommon StockSEC:0001437749-21-011553:1
  • ◇
    DirectorExecutivesVaxart, Inc.
    170,000 USD11SEC
    100,000 shares@ US$1.703.4% of flowCommon StockSEC:0001437749-21-011553:2
  • ▼
    DirectorExecutivesVaxart, Inc.
    713,000 USD12SEC
    100,000 shares@ US$7.1314.3% of flowCommon StockSEC:0001437749-21-011553:3
  • ◇
    DirectorExecutivesVaxart, Inc.
    170,000 USD19SEC
    100,000 shares@ US$1.70100.0% of flowCommon StockSEC:0001437749-21-011553:0
  • ◇
    DirectorExecutivesVaxart, Inc.
    115,500 USD11SEC
    150,000 shares@ US$0.773.4% of flowCommon StockSEC:0001437749-21-005145:0
  • ▼
    DirectorExecutivesVaxart, Inc.
    906,450 USD14SEC
    150,000 shares@ US$6.04326.4% of flowCommon StockSEC:0001437749-21-005145:1
  • ▼
    DirectorExecutivesVaxart, Inc.
    2M USD19SEC
    333,334 shares@ US$6.324490.6% of flowCommon StockSEC:0001437749-20-024358:0
  • ◆
    DirectorExecutivesVaxart, Inc.
    50,000 USD13SEC
    166,667 shares@ US$0.302.1% of flowCommon stockSEC:0001437749-20-017670:0
  • ▲
    President and Chief ExecutiveExecutivesVaxart, Inc.
    50,000 USD34SEC
    166,667 shares@ US$0.302.3% of flowCommon stockSEC:0001437749-19-019280:0
    Canonical exit: 29 Dec 2019 (T+90)

9 of 9 declarations